Precision Medicine and Clinical Ophthalmology
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
Citing Articles
Evaluating deep learning models for classifying OCT images with limited data and noisy labels.
Miladinovic A, Biscontin A, Ajcevic M, Kresevic S, Accardo A, Marangoni D Sci Rep. 2024; 14(1):30321.
PMID: 39638854 PMC: 11621707. DOI: 10.1038/s41598-024-81127-1.
Biomarkers of Neurodegeneration and Precision Therapy in Retinal Disease.
Micera A, Balzamino B, Di Zazzo A, Dinice L, Bonini S, Coassin M Front Pharmacol. 2021; 11:601647.
PMID: 33584278 PMC: 7873955. DOI: 10.3389/fphar.2020.601647.
References
1.
Young T, Burgess B, Rao N, Glasgow B, Straatsma B
. Transscleral fine-needle aspiration biopsy of macular choroidal melanoma. Am J Ophthalmol. 2007; 145(2):297-302.
DOI: 10.1016/j.ajo.2007.09.028.
View
2.
McCannel T, Burgess B, Nelson S, Eskin A, Straatsma B
. Genomic identification of significant targets in ciliochoroidal melanoma. Invest Ophthalmol Vis Sci. 2010; 52(6):3018-22.
DOI: 10.1167/iovs.10-5864.
View
3.
Russell S, Bennett J, Wellman J, Chung D, Yu Z, Tillman A
. Efficacy and safety of voretigene neparvovec (AAV2-hRPE65v2) in patients with RPE65-mediated inherited retinal dystrophy: a randomised, controlled, open-label, phase 3 trial. Lancet. 2017; 390(10097):849-860.
PMC: 5726391.
DOI: 10.1016/S0140-6736(17)31868-8.
View
4.
Joachim N, Kifley A, Colijn J, Lee K, Buitendijk G, Klein B
. Joint Contribution of Genetic Susceptibility and Modifiable Factors to the Progression of Age-Related Macular Degeneration over 10 Years: The Three Continent AMD Consortium Report. Ophthalmol Retina. 2019; 2(7):684-693.
DOI: 10.1016/j.oret.2017.10.019.
View